NetworkNewsBreaks

MondayMay 12, 2025 11:06 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Q1 2025 Results on May 15 

NRx Pharmaceuticals (NASDAQ: NRXP) announced it will release its first quarter 2025 financial results after market close on Thursday, May 15, 2025. The company will host a conference call at 4:30 p.m. ET the same day to discuss the results and provide a corporate update.  To view the full press release, visit https://nnw.fm/UGA07  About NRx Pharmaceuticals, Inc.  NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant…

Continue Reading

MondayMay 12, 2025 10:50 am

NetworkNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Plans $1 Million Private Placement with Major Shareholder HCI

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) announced plans to raise approximately $1.01 million through a private placement of 800,000 common shares at $1.26 per share to major shareholder Hosken Consolidated Investments Limited ("HCI"), pending regulatory approval. The proceeds will support the company's share of pre-construction activities at the Waterberg Project in South Africa and general corporate needs. The placement price reflects a 3.1% premium to the five-day VWAP on NYSE American as of May 9. Upon completion, HCI will return to a 26% ownership stake. The shares will be subject to a four-month-plus-one-day resale restriction and were offered…

Continue Reading

MondayMay 12, 2025 9:10 am

NetworkNewsBreaks – NUBURU, Inc. (NYSE American: BURU) Receives Noncompliance Notice from NYSE American Over Equity Threshold

NUBURU (NYSE American: BURU) has received a Notice of Noncompliance from NYSE Regulation for failing to meet the $2 million stockholders’ equity requirement under Section 1003(a)(i) of the NYSE American Company Guide, following continued operating losses and a going concern warning in its latest 10-K. The notice does not immediately impact BURU's trading status, though its ticker now carries a ".BC" designation. The company has until May 29 to submit a plan to regain compliance and until Oct. 29, 2026 to meet the listing standards. Management cited recent strategic initiatives as potential paths to compliance, though their success is not…

Continue Reading

FridayMay 09, 2025 3:17 pm

NetworkNewsBreaks – Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Flagship Project Poised to Meet Surging Global PGM Needs

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is advancing the development of its Waterberg Project in South Africa, a large-scale platinum group metals (“PGM”) mine expected to be among the world’s largest and lowest-cost underground operations. In September 2024, an independent definitive feasibility study (“DFS”) was completed for Waterberg, highlighting its robust economics, including projected steady state annual production of 353,208 ounces of platinum, palladium, rhodium and gold, along with significant copper and nickel by-products, over a 54-year mine life. Located in the Bushveld Complex, the project features thick, shallow ore bodies allowing for safer, more efficient mining. Amid rising…

Continue Reading

FridayMay 09, 2025 2:39 pm

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Eyes Game-Changing Approach to Cancer Treatment

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its innovative RTNova platform, which has successfully delivered transient gene-therapy payloads to targeted tumors. In addition, Calidi’s virotherapy demonstrated efficacy in killing more than 60 different tumor cell lines, showcasing the platform’s potential to revolutionize cancer treatment by enabling both tumor destruction and robust immune activation. “Targeting tumors with a systemic virotherapy with a multimodal mechanism of action, which includes direct killing of the tumors and robust activation of antitumor immune responses, may revolutionize the way we approach cancer treatments,” said a Calidi spokesman. “We are excited to have shown…

Continue Reading

FridayMay 09, 2025 1:10 pm

NetworkNewsBreaks – Spotlight on Nuclear: DealFlow Discovery Day Set to Energize Investment

DealFlow Events today announced the launch of the inaugural DealFlow Discovery Day on Nuclear Energy, slated to take place in New York City on May 22, 2025. The event provides a forum for discovering new investment opportunities and exchanging ideas with industry stakeholders including utilities, financiers, site developers, technology providers, and government entities. Especially timely in light of the renaissance in the nuclear energy sector on the back of strong demand for clean energy and the intensive operations of data centers and AI technologies, the event will feature an insights-packed agenda. Thought leaders and top management of companies in the…

Continue Reading

FridayMay 09, 2025 11:50 am

NetworkNewsBreaks – NUBURU, Inc. (NYSE American: BURU) Launches Strategic Revamp of Blue-Laser Unit with Defense Focus

NUBURU (NYSE American: BURU) has announced the formation of a strategic working group to revitalize its Blue-Laser Business Unit, aiming to strengthen its position in the defense sector. The move follows a Joint-Pursuit Agreement with a defense-tech partner and plans to introduce vertical applications that enable cross-selling to existing and new clients. NUBURU is also advancing discussions to bring in a senior revenue and marketing strategist, while leveraging AI-driven insights from NexGenAI Solutions Group. The initiative includes the development of a new state-of-the-art operational facility to support this next phase of growth. To view the full press release, visit https://nnw.fm/qJieB…

Continue Reading

FridayMay 09, 2025 11:15 am

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Reports Record Revenue, Gross Profit and Cash Balance along with Quantum Supremacy Breakthrough in Q1

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, posted record first quarter 2025 revenue of $15 million, up 509% from the prior year. Business and financial results for the quarter included the first Advantage™ annealing quantum computer sale and publication of breakthrough research demonstrating quantum supremacy on a real-world problem. The company ended the quarter with a record $304.3 million in cash on hand. Consolidated gross margin rose to 92.5%, with the company citing sufficient liquidity to reach profitability. To view the full press release, visit https://nnw.fm/MtI0T About D-Wave Quantum Inc. D-Wave is a leader…

Continue Reading

FridayMay 09, 2025 9:10 am

NetworkNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) Files C$200 Million Shelf Prospectus for Flexible Future Offerings

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) has filed a final short form base shelf prospectus with Canadian securities regulators, replacing its previous version set to expire in June 2025. The new Shelf Prospectus allows the company to offer up to C$200 million in securities—including common shares, debt instruments, warrants, and units—over the next 25 months. A corresponding Form F-10 registration has been filed with the U.S. SEC but is not yet effective. Proceeds from any future offerings will support business development, working capital, debt repayment, capital programs, and potential To view the full press release,…

Continue Reading

ThursdayMay 08, 2025 3:36 pm

NetworkNewsBreaks – Adageis’ AI-Powered Platform Empowers Smarter Billing, Better Care

Adageis, a healthcare technology company, is transforming how providers manage insurance payments with its AI-driven software platform, designed to enhance transparency, ensure reimbursement, and support the shift to value-based care. By offering real-time insights into expected payments, identifying reimbursement gaps, and evaluating performance, Adageis empowers clinics—especially smaller or new practices—to optimize revenue, negotiate better insurance contracts, and make informed financial decisions. The platform helps providers navigate complex insurance arrangements while improving profitability, quality, and a focus on patient care. With growing interest in the healthcare technology sector, Adageis stands out as a promising investment opportunity. To view the full article,…

Continue Reading